Welcome to CellCure™

CellCure™ is a Danish biotech company that develops cancer therapy by applying T-cell based specific immune therapy. The technology is based on many years of research at the University of Aarhus showing that T-lymphocytes can be cultured in unlimited amounts (continuous T-cell lines). The company lead product is a potential breakthrough in the treatment of metastatic malignant melanoma (birthmark cancer). The technology has the potential for a wider application in other cancer forms.